Therefore, it might be predicted that reduced ACE2 activity in COVID-19 would have a relatively larger impact on Ang 1–7 levels than on Ang II levels, which would be expected to rapidly decline as a result of the AT1R short-loop negative feedback mechanism (20). This evidence concerns the gene ACE2 and COVID-19.